Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Martin Mørck Mortensen"'
Autor:
Marianne Trier Bjerre, Maibritt Nørgaard, Ole Halfdan Larsen, Sarah Østrup Jensen, Siri H. Strand, Peter Østergren, Mikkel Fode, Jacob Fredsøe, Benedicte Parm Ulhøi, Martin Mørck Mortensen, Jørgen Bjerggaard Jensen, Michael Borre, Karina D. Sørensen
Publikováno v:
Cells, Vol 9, Iss 6, p 1362 (2020)
Novel and minimally-invasive prostate cancer (PCa)-specific biomarkers are needed to improve diagnosis and risk stratification. Here, we investigated the biomarker potential in localized and de novo metastatic PCa (mPCa) of methylated circulating tum
Externí odkaz:
https://doaj.org/article/86c71c7548184366b907a553ec0a82a5
Autor:
Siri H. Strand, Maibritt Nørgaard, Martin Mørck Mortensen, Jørgen Bjerggaard Jensen, Sarah Østrup Jensen, Ole Halfdan Larsen, Karina Dalsgaard Sørensen, Michael Borre, Jacob Fredsøe, Benedicte Parm Ulhøi, Mikkel Fode, Marianne Bjerre, Peter Busch Østergren
Publikováno v:
Bjerre, M T, Nørgaard, M, Larsen, O H, Jensen, S Ø, Strand, S H, Østergren, P, Fode, M, Fredsøe, J, Ulhøi, B P, Mortensen, M M, Jensen, J B, Borre, M & Sørensen, K D 2020, ' Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer : Evaluation of Clinical Biomarker Potential ', Cells, vol. 9, no. 6, 1362 . https://doi.org/10.3390/cells9061362
Cells, Vol 9, Iss 1362, p 1362 (2020)
Cells
Volume 9
Issue 6
Cells, Vol 9, Iss 1362, p 1362 (2020)
Cells
Volume 9
Issue 6
Novel and minimally-invasive prostate cancer (PCa)-specific biomarkers are needed to improve diagnosis and risk stratification. Here, we investigated the biomarker potential in localized and de novo metastatic PCa (mPCa) of methylated circulating tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1f09bf3bfe7eaa1b01a83f9eed3490
https://pure.au.dk/portal/da/publications/epigenetic-analysis-of-circulating-tumor-dna-in-localized-and-metastatic-prostate-cancer(f6d830fb-a791-4f43-91a9-56e6d82f1bb7).html
https://pure.au.dk/portal/da/publications/epigenetic-analysis-of-circulating-tumor-dna-in-localized-and-metastatic-prostate-cancer(f6d830fb-a791-4f43-91a9-56e6d82f1bb7).html
Autor:
Peter Mouritzen, Maibritt Nørgaard, Helle Kristensen, Martin Mørck Mortensen, Torben F. Ørntoft, Siri H. Strand, Karina Dalsgaard Sørensen, Michael Borre, Jacob Fredsøe, Marianne Bjerre, Benedicte Parm Ulhøi, Anne K.I. Rasmussen
Publikováno v:
Bjerre, M T, Strand, S H, Nørgaard, M, Kristensen, H, Rasmussen, A K, Mortensen, M M, Fredsøe, J, Mouritzen, P, Ulhøi, B, Ørntoft, T, Borre, M & Sørensen, K D 2019, ' Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer ', International Journal of Molecular Sciences, vol. 20, no. 5, 1173 . https://doi.org/10.3390/ijms20051173
International Journal of Molecular Sciences
Volume 20
Issue 5
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1173 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 5
International Journal of Molecular Sciences, Vol 20, Iss 5, p 1173 (2019)
Prostate cancer (PCa) is a clinically heterogeneous disease and currently, accurate diagnostic and prognostic molecular biomarkers are lacking. This study aimed to identify novel DNA hypermethylation markers for PCa with future potential for blood-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69dd0edb68be6a1028d821277ca3a26b
https://pure.au.dk/portal/da/publications/aberrant-dock2-grasp-hif3a-and-pkfp-hypermethylation-has-potential-as-a-prognostic-biomarker-for-prostate-cancer(3fa44415-87ae-4937-b2f7-20178c3e06a3).html
https://pure.au.dk/portal/da/publications/aberrant-dock2-grasp-hif3a-and-pkfp-hypermethylation-has-potential-as-a-prognostic-biomarker-for-prostate-cancer(3fa44415-87ae-4937-b2f7-20178c3e06a3).html
Autor:
Marianne T, Bjerre, Siri H, Strand, Maibritt, Nørgaard, Helle, Kristensen, Anne Ki, Rasmussen, Martin Mørck, Mortensen, Jacob, Fredsøe, Peter, Mouritzen, Benedicte, Ulhøi, Torben, Ørntoft, Michael, Borre, Karina D, Sørensen
Publikováno v:
International Journal of Molecular Sciences
Prostate cancer (PCa) is a clinically heterogeneous disease and currently, accurate diagnostic and prognostic molecular biomarkers are lacking. This study aimed to identify novel DNA hypermethylation markers for PCa with future potential for blood-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b56944a7c1401013330613394bf787b7
https://pubmed.ncbi.nlm.nih.gov/30866497
https://pubmed.ncbi.nlm.nih.gov/30866497
Autor:
Christian Arsov, Karina Dalsgaard Sørensen, Marie Stampe Ostenfeld, Michael Borre, Siri H. Strand, Helle Kristensen, Kasper Thorsen, Tapio Visakorpi, Martin Mørck Mortensen, Søren Svane Hoyer, Torben F. Ørntoft, Kamilla Mundbjerg, Peter J. Wild, Henrik Grönberg, Wolfgang Goering, Lars Egevad, Christa Haldrup, Johan Lindberg
Publikováno v:
Kristensen, H, Haldrup, C, Strand, S, Mundbjerg, K, Mortensen, M M, Thorsen, K, Ostenfeld, M S, Wild, P J, Arsov, C, Goering, W, Visakorpi, T, Egevad, L, Lindberg, J, Grönberg, H, Høyer, S, Borre, M, Orntoft, T F & Sørensen, K D 2014, ' Hypermethylation of the GABRE~miR-452~miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy ', Clinical Cancer Research, vol. 20, no. 8, pp. 2169-81 . https://doi.org/10.1158/1078-0432.CCR-13-2642
Purpose: Available tools for prostate cancer diagnosis and prognosis are suboptimal and novel biomarkers are urgently needed. Here, we investigated the regulation and biomarker potential of the GABRE∼miR-452∼miR-224 genomic locus. Experimental De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42881e018f180daa7c9010098feb95ff
https://doi.org/10.1158/1078-0432.ccr-13-2642
https://doi.org/10.1158/1078-0432.ccr-13-2642
Autor:
Mohammad Asim, Silvia Halim, Martin Mørck Mortensen, Hayley C. Whitaker, Adele Murrell, Anne Y. Warren, Simon A. Gayther, Alastair D. Lamb, Ian G. Mills, Jonathan D. Kay, Stephen J. Ball, Sebastian M. Armasu, Antonio Ramos-Montoya, Karina Dalsgaard Sørensen, Siri H. Strand, Claire M. Wells, Michael Borre, Kathryn Woodfine, Melissa C. Larson, Charles E. Massie, Kate Lawrenson, Ellen L. Goode, David E. Neal, Roslin Russell, Torben F. Ørntoft, Brooke L. Fridley, John R. W. Masters, Helen Ross-Adams
Publikováno v:
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget . https://doi.org/10.18632/oncotarget.12543
Oncotarget
Ross-Adams, H, Ball, S J, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S, Ørntoft, T F, Larson, M C, Armasu, S M, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J R, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', OncoTarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S H, Ørntoft, T F, Larson, M, Armasu, S, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', Oncotarget . https://doi.org/10.18632/oncotarget.12543
Oncotarget
Ross-Adams, H, Ball, S J, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, S, Ørntoft, T F, Larson, M C, Armasu, S M, Massie, C E, Asim, M, Mortensen, M M, Borre, M, Woodfine, K, Warren, A Y, Lamb, A D, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, K D, Fridley, B L, Goode, E L, Gayther, S A, Masters, J R, Neal, D E & Mills, I G 2016, ' HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer ', OncoTarget, vol. 7, no. 46, pp. 74734-74746 . https://doi.org/10.18632/oncotarget.12543
Two independent regions within HNF1B are consistently identified in prostate and ovarian cancer genome-wide association studies (GWAS); their functional roles are unclear. We link prostate cancer (PC) risk SNPs rs11649743 and rs3760511 with elevated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1087fbe6b7f09cc62ecb72e3ad4e3d33
https://kclpure.kcl.ac.uk/en/publications/9de950f5-0783-47e3-8734-2c4c386c1c49
https://kclpure.kcl.ac.uk/en/publications/9de950f5-0783-47e3-8734-2c4c386c1c49
Publikováno v:
Bentzon, D N, Borre, M, Ørntoft, T F, Mortensen, M M & Andersen, L D 2012, ' Expression Profiling of Hereditary versus Sporadic Prostate Cancer Suggests CYR61, EGR3, KLF6 and SNF1LK as Differentially Expressed Genes ', Open Journal of Urology, pp. 45-54 .
Aarhus University
Aarhus University
Background: Distinguishing between sub-clinical and aggressive forms of prostate cancer is difficult due to the heterogeneity of the disease. It is, however, important to identify aggressive forms to guide proper treatment. This study compared gene e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1e5cc1689faf5354ae647d31725e5d
https://pure.au.dk/portal/da/publications/expression-profiling-of-hereditary-versus-sporadic-prostate-cancer-suggests-cyr61-egr3-klf6-and-snf1lk-as-differentially-expressed-genes(fa66c609-845c-4e3c-bf62-e54466f4daeb).html
https://pure.au.dk/portal/da/publications/expression-profiling-of-hereditary-versus-sporadic-prostate-cancer-suggests-cyr61-egr3-klf6-and-snf1lk-as-differentially-expressed-genes(fa66c609-845c-4e3c-bf62-e54466f4daeb).html
Autor:
Martin Mørck Mortensen, Helle Kristensen, Karina Dalsgaard Sørensen, Niels Tørring, Michael Borre, Peter D. Ottosen, Mette Opstrup Abildgaard, Peter J. Wild, Lars Dyrskjøt, Francisco Mansilla, Torben F. Ørntoft, Benedicte Parm Ulhøi
Publikováno v:
International journal of cancer. 130(4)
This study investigates the expression and biomarker potential of zinc finger protein 132 (ZNF132) in prostate cancer (PC) by transcriptional profiling and immunohistochemical analysis of tissue microarrays, including tumor specimens from 615 radical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa14e6ec342bfb57d27af830a407ba8f
https://pubmed.ncbi.nlm.nih.gov/21445975
https://pubmed.ncbi.nlm.nih.gov/21445975
Publikováno v:
Mortensen, M M, Mortensen, P S & Borre, M 2009, ' Percentage of tumour-positive biopsy cores: an independent predictor of extraprostatic disease ', Scandinavian Journal of Urology and Nephrology, vol. 43, no. 2, pp. 109-13 . https://doi.org/10.1080/00365590802670348
Udgivelsesdato: 2009-null OBJECTIVE: Preoperative staging of patients diagnosed with prostate cancer is vital in determining the correct treatment including radical prostatectomy. Serum prostate-specific antigen (PSA), Gleason score in prostate biops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58d24ea5129c8f30844e0073f90f231
https://pubmed.ncbi.nlm.nih.gov/19242861
https://pubmed.ncbi.nlm.nih.gov/19242861
Autor:
Martin Mørck Mortensen, Jens Vinge Nygaard, Jesper Langhoff Hønge, Dang Lee, John Michael Hasenkam
Publikováno v:
Mortensen, M M, Nygaard, J V, Hønge, J L, Lee, D & Hasenkam, J M 2009, ' Development and evaluation of a tissue-engineered trilaminar scaffold for heart valve replacement, Martin Mortensen ', iNANO 7 th annual meeting, Aarhus, Denmark, 17/12/2010 .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9b0ab43e88a039023c2332d992a4a87e
https://pure.au.dk/portal/da/publications/development-and-evaluation-of-a-tissueengineered-trilaminar-scaffold-for-heart-valve-replacement-martin-mortensen(f41565d0-f82e-11dd-8f9a-000ea68e967b).html
https://pure.au.dk/portal/da/publications/development-and-evaluation-of-a-tissueengineered-trilaminar-scaffold-for-heart-valve-replacement-martin-mortensen(f41565d0-f82e-11dd-8f9a-000ea68e967b).html